Evidence map›Paper›PMID 27280788›Full record

ArticleG3 (Bethesda, Md.)2016

Synthetic Physical Interactions Map Kinetochore-Checkpoint Activation Regions.

Guðjón Ólafsson, Peter H Thorpe

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Yeast goes viral: probing SARS-CoV-2 biology usingMicrobial cell (Graz, Austria) · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Guðjón ÓlafssonThe Francis Crick Institute, Mill Hill Laboratory, London, NW7 1AA, United Kingdom.
Peter H ThorpeThe Francis Crick Institute, Mill Hill Laboratory, London, NW7 1AA, United Kingdom peter.thorpe@crick.ac.uk.ORCID 0000-0003-1649-6816
The Francis Crick Institute · GB

Funding

Cancer Research UKMedical Research Council MC_UP_A252_1027Wellcome Trust
6 · The paper itself

Abstract

The spindle assembly checkpoint (SAC) is a key mechanism to regulate the timing of mitosis and ensure that chromosomes are correctly segregated to daughter cells. The recruitment of the Mad1 and Mad2 proteins to the kinetochore is normally necessary for SAC activation. This recruitment is coordinated by the SAC kinase Mps1, which phosphorylates residues at the kinetochore to facilitate binding of Bub1, Bub3, Mad1, and Mad2. There is evidence that the essential function of Mps1 is to direct recruitment of Mad1/2. To test this model, we have systematically recruited Mad1, Mad2, and Mps1 to most proteins in the yeast kinetochore, and find that, while Mps1 is sufficient for checkpoint activation, recruitment of either Mad1 or Mad2 is not. These data indicate an important role for Mps1 phosphorylation in SAC activation, beyond the direct recruitment of Mad1 and Mad2.

Indexed as

Cell Cycle CheckpointsCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsKinetochoresMad2 ProteinsMicroscopy, FluorescenceMutationNuclear ProteinsPhosphorylationProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSpindle ApparatusCell Cycle ProteinsChromosomal Proteins, Non-HistoneCSE4 protein, S cerevisiaeDNA-Binding ProteinsMAD1 protein, S cerevisiaeMad2 ProteinsMAD2 protein, S cerevisiaeMPS1 protein, S cerevisiaeNDC80 protein, S cerevisiaeNuclear ProteinsProtein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinskinetochoreMad1Mad2Mps1SAC

Identifiers

PMID27280788
PMCPMC4978906
OpenAlexW2412947049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.